Arena Pharmaceuticals - Stock Price History | ARNA

Historical daily share price chart and data for Arena Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Arena Pharmaceuticals as of September 16, 2021 is 59.95.
  • The all-time high Arena Pharmaceuticals stock closing price was 462.50 on August 31, 2000.
  • The Arena Pharmaceuticals 52-week high stock price is 90.19, which is 50.4% above the current share price.
  • The Arena Pharmaceuticals 52-week low stock price is 45.50, which is 24.1% below the current share price.
  • The average Arena Pharmaceuticals stock price for the last 52 weeks is 69.47.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Arena Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 60.7632 46.2400 87.7100 34.8300 76.8300 69.15%
2019 50.3058 40.2200 63.3300 39.5400 45.4200 16.61%
2018 40.4410 36.2100 49.6300 30.8900 38.9500 14.66%
2017 20.0076 14.7000 34.6600 11.5000 33.9700 139.23%
2016 16.5036 18.3000 21.5000 13.5000 14.2000 -25.26%
2015 35.8980 35.9000 60.5000 17.0000 19.0000 -45.24%
2014 53.4490 58.7000 77.2000 33.7000 34.7000 -40.68%
2013 71.6921 90.1000 108.1000 40.8000 58.5000 -35.14%
2012 62.7528 19.2000 118.1000 15.6000 90.2000 382.35%
2011 15.0441 17.7000 21.9000 12.3000 18.7000 8.72%
2010 33.1954 35.3000 79.5000 12.7000 17.2000 -51.55%
2009 40.8730 42.5000 71.5000 23.2000 35.5000 -14.87%
2008 55.5846 76.7000 84.8000 29.3000 41.7000 -46.74%
2007 116.7563 127.2000 145.7000 78.3000 78.3000 -39.35%
2006 140.1357 154.5000 204.3000 92.3000 129.1000 -9.15%
2005 78.8363 65.0000 144.9000 49.2000 142.1000 112.09%
2004 54.1374 64.1000 70.0000 35.7000 67.0000 8.06%
2003 69.0024 66.5000 85.4000 61.4900 62.0000 -4.76%
2002 78.8792 121.7000 123.2000 53.6000 65.1000 -45.89%
2001 191.0484 141.3000 354.7000 90.0000 120.3000 -22.39%
2000 305.2417 250.0000 462.5000 140.6000 155.0000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.609B $0.000B
Arena Pharmaceuticals is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs. BELVIQ (lorcaserin HCl), their internally discovered drug for chronic weight management, is their first and only drug approved by any regulatory agency for marketing. BELVIQ was approved by the US Food and Drug Administration, or FDA, for marketing in the United States, and was made available by prescription in June 2013 to adults who are overweight with a comorbidity or obese. They are exploring BELVIQ for possible new indications, using different formulations, and in combination with other drugs.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $175.368B 54.17
Bristol Myers Squibb (BMY) United States $137.771B 9.17
Amgen (AMGN) United States $123.866B 13.41
CSL (CSLLY) Australia $102.597B 0.00
Gilead Sciences (GILD) United States $89.973B 8.70
BioNTech SE (BNTX) Germany $86.154B 18.59
Regeneron Pharmaceuticals (REGN) United States $69.735B 11.97
Illumina (ILMN) United States $65.997B 74.98
Vertex Pharmaceuticals (VRTX) United States $48.996B 19.04
Biogen (BIIB) United States $44.592B 12.24
BeiGene (BGNE) Cayman Islands $34.845B 0.00
Genmab (GMAB) Denmark $28.151B 69.13
Seagen (SGEN) United States $27.670B 46.65
Genmab (GNMSF) Denmark $27.591B 68.97
Horizon Therapeutics Public (HZNP) Ireland $23.961B 22.71
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.282B 0.00
Bio-Techne Corp (TECH) United States $20.698B 93.08
Exact Sciences (EXAS) United States $17.994B 0.00
Novavax (NVAX) United States $17.303B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.550B 0.00
Repligen (RGEN) United States $16.274B 124.02
Incyte (INCY) United States $16.218B 38.45
BioMarin Pharmaceutical (BMRN) United States $14.168B 101.67
Guardant Health (GH) United States $12.865B 0.00
QIAGEN (QGEN) Netherlands $12.195B 20.65
Zai Lab (ZLAB) China $11.901B 0.00
Intellia Therapeutics (NTLA) United States $11.055B 0.00
CureVac (CVAC) Germany $10.540B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.935B 22.95
Biohaven Pharmaceutical Holding (BHVN) United States $8.894B 0.00
Ascendis Pharma (ASND) Denmark $8.873B 0.00
Mirati Therapeutics (MRTX) United States $8.677B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.170B 0.00
Vir Biotechnology (VIR) United States $6.832B 0.00
Beam Therapeutics (BEAM) United States $6.775B 0.00
Sarepta Therapeutics (SRPT) United States $6.711B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.580B 0.00
Exelixis (EXEL) United States $6.449B 70.59
Denali Therapeutics (DNLI) United States $6.402B 181.48
Fate Therapeutics (FATE) United States $6.330B 0.00
Blueprint Medicines (BPMC) United States $6.076B 17.15
Halozyme Therapeutics (HALO) United States $5.871B 23.98
Legend Biotech (LEGN) United States $5.871B 0.00
NeoGenomics (NEO) United States $5.802B 786.33
Twist Bioscience (TWST) United States $5.568B 0.00
Certara (CERT) United States $5.524B 0.00
I-Mab (IMAB) China $5.243B 0.00
AbCellera Biologics (ABCL) $5.242B 0.00
Adaptive Biotechnologies (ADPT) United States $5.153B 0.00
Alkermes (ALKS) Ireland $4.951B 146.14
Arvinas (ARVN) United States $4.668B 0.00
Editas Medicine (EDIT) United States $4.116B 0.00
Reata Pharmaceuticals (RETA) United States $3.859B 0.00
Galapagos (GLPG) Belgium $3.634B 0.00
SpringWorks Therapeutics (SWTX) United States $3.544B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Kymera Therapeutics (KYMR) United States $3.317B 0.00
Prothena (PRTA) Ireland $3.305B 0.00
Insmed (INSM) United States $3.185B 0.00
ALX Oncology Holdings (ALXO) United States $3.154B 0.00
Emergent Biosolutions (EBS) United States $3.069B 7.40
Amicus Therapeutics (FOLD) United States $2.969B 0.00
Apellis Pharmaceuticals (APLS) United States $2.951B 0.00
Cytokinetics (CYTK) United States $2.814B 0.00
Intra-Cellular Therapies (ITCI) United States $2.723B 0.00
Heska (HSKA) United States $2.701B 517.80
ACADIA Pharmaceuticals (ACAD) United States $2.554B 0.00
Myriad Genetics (MYGN) United States $2.554B 0.00
Seer (SEER) $2.493B 0.00
Instil Bio (TIL) United States $2.476B 0.00
Celldex Therapeutics (CLDX) United States $2.473B 0.00
Morphic Holding (MORF) United States $2.442B 0.00
Arcus Biosciences (RCUS) United States $2.382B 0.00
Vericel (VCEL) United States $2.378B 283.33
Sorrento Therapeutics (SRNE) United States $2.367B 0.00
C4 Therapeutics (CCCC) United States $2.364B 0.00
Ligand Pharmaceuticals (LGND) United States $2.266B 33.14
Protagonist Therapeutics (PTGX) United States $2.210B 0.00
Atea Pharmaceuticals (AVIR) United States $2.151B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.072B 35.29
Amarin (AMRN) Ireland $2.040B 516.00
Myovant Sciences (MYOV) United Kingdom $2.010B 0.00
NGM Biopharmaceuticals (NGM) United States $1.983B 0.00
Alector (ALEC) United States $1.962B 0.00
REGENXBIO (RGNX) United States $1.924B 0.00
Revance Therapeutics (RVNC) United States $1.905B 0.00
Castle Biosciences (CSTL) United States $1.881B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.830B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.802B 0.00
Berkeley Lights (BLI) United States $1.786B 0.00
PHARMA MAR SA (PHMMF) Spain $1.737B 0.00
UniQure (QURE) Netherlands $1.676B 5.70
MorphoSys AG (MOR) Germany $1.671B 0.00
Dynavax Technologies (DVAX) United States $1.662B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.649B 0.00
Global Blood Therapeutics (GBT) United States $1.621B 0.00
Nurix Therapeutics (NRIX) United States $1.616B 0.00
Codexis (CDXS) United States $1.600B 0.00
Inovio Pharmaceuticals (INO) United States $1.592B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.563B 0.00
MaxCyte (MXCT) United States $1.541B 0.00
Zymeworks (ZYME) Canada $1.532B 0.00
Kadmon Holdings (KDMN) United States $1.517B 0.00
Ocugen (OCGN) United States $1.497B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.475B 0.00
Bionano Genomics (BNGO) United States $1.474B 0.00
Travere Therapeutics (TVTX) United States $1.429B 0.00
Genetron Holdings (GTH) China $1.420B 0.00
PureTech Health (PRTC) United States $1.418B 0.00
Zealand Pharma (ZEAL) Denmark $1.398B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.393B 0.00
Scholar Rock Holding (SRRK) United States $1.380B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.377B 0.00
Inhibrx (INBX) United States $1.372B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Agenus (AGEN) United States $1.253B 0.00
BioAtla (BCAB) United States $1.246B 0.00
Coherus BioSciences (CHRS) United States $1.208B 0.00
Bluebird Bio (BLUE) United States $1.203B 0.00
Avid Bioservices (CDMO) United States $1.169B 238.13
MannKind (MNKD) United States $1.166B 0.00
Repare Therapeutics (RPTX) Canada $1.143B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.143B 0.00
Precigen (PGEN) United States $1.130B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.117B 0.00
RAPT THERAPTICS (RAPT) United States $1.105B 0.00
Fulcrum Therapeutics (FULC) United States $1.087B 0.00
Northwest Biotherapeutics (NWBO) United States $1.075B 0.00
ImmunityBio (IBRX) United States $1.046B 0.00
IDEAYA Biosciences (IDYA) United States $1.002B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.983B 0.00
Nkarta (NKTX) United States $0.968B 0.00
Prometheus Biosciences (RXDX) United States $0.949B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.941B 0.00
Sutro Biopharma (STRO) United States $0.922B 0.00
Immatics (IMTX) Germany $0.920B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.909B 28.17
BeyondSpring (BYSI) United States $0.898B 0.00
Avidity Biosciences (RNA) United States $0.862B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Shattuck Labs (STTK) United States $0.842B 0.00
Mesoblast (MESO) Australia $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Curis (CRIS) United States $0.765B 0.00
Precision BioSciences (DTIL) United States $0.741B 0.00
Cara Therapeutics (CARA) United States $0.740B 92.31
Keros Therapeutics (KROS) United States $0.728B 0.00
Amryt Pharma (AMYT) United Kingdom $0.717B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.711B 0.00
AnaptysBio (ANAB) United States $0.709B 0.00
Pliant Therapeutics (PLRX) United States $0.677B 0.00
Adagene (ADAG) China $0.665B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.656B 11.95
Mersana Therapeutics (MRSN) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Cellectis S.A (CLLS) France $0.636B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.633B 0.00
Gritstone Bio (GRTS) United States $0.632B 0.00
Ambrx Biopharma (AMAM) United States $0.629B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
MiMedx (MDXG) United States $0.626B 0.00
Affimed (AFMD) Germany $0.622B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.620B 0.00
Akoya Biosciences (AKYA) United States $0.617B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
Spero Therapeutics (SPRO) United States $0.596B 0.00
Bolt Biotherapeutics (BOLT) United States $0.595B 0.00
G1 THERAPEUTICS (GTHX) United States $0.590B 0.00
Seres Therapeutics (MCRB) United States $0.582B 0.00
Anika Therapeutics (ANIK) United States $0.574B 0.00
DBV Technologies S.A (DBVT) France $0.573B 0.00
MeiraGTx Holdings (MGTX) United States $0.569B 0.00
VistaGen Therapeutics (VTGN) United States $0.563B 0.00
ALBIREO PHARMA (ALBO) United States $0.563B 0.00
Vaccitech (VACC) United Kingdom $0.553B 0.00
Epizyme (EPZM) United States $0.550B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.527B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Inventiva S.A (IVA) France $0.522B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.501B 0.00
AC Immune SA (ACIU) Switzerland $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Selecta Biosciences (SELB) United States $0.491B 0.00
Cel-Sci (CVM) United States $0.481B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.480B 0.00
XBiotech (XBIT) United States $0.479B 0.00
Verastem (VSTM) United States $0.461B 0.00
Clene (CLNN) United States $0.457B 0.00
ChromaDex (CDXC) United States $0.455B 0.00
Bellus Health (BLU) Canada $0.454B 0.00
Innate Pharma S.A (IPHA) France $0.442B 0.00
Geron (GERN) United States $0.436B 0.00
Oncobiologics (OTLK) United States $0.424B 0.00
Compugen (CGEN) Israel $0.419B 0.00
Arbutus Biopharma (ABUS) United States $0.418B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.415B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.415B 0.00
BioDelivery Sciences (BDSI) United States $0.410B 12.61
Codiak BioSciences (CDAK) United States $0.403B 0.00
SQZ Biotechnologies (SQZ) United States $0.398B 0.00
Clearside Biomedical (CLSD) United States $0.391B 0.00
Starpharma Holdings (SPHRY) Australia $0.390B 0.00
Cue Biopharma (CUE) United States $0.382B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.381B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.371B 0.00
Athenex (ATNX) United States $0.371B 0.00
Cybin (CYBN) Canada $0.368B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.364B 0.00
ANI Pharmaceuticals (ANIP) United States $0.350B 9.54
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
Neoleukin Therapeutics (NLTX) United States $0.341B 0.00
Opthea (OPT) Australia $0.338B 0.00
Fortress Biotech (FBIO) United States $0.335B 0.00
Athersys (ATHX) United States $0.333B 0.00
Prima BioMed (IMMP) Australia $0.327B 0.00
Cogent Biosciences (COGT) United States $0.325B 0.00
Syros Pharmaceuticals (SYRS) United States $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Angion Biomedica (ANGN) United States $0.319B 0.00
INmune Bio (INMB) United States $0.312B 0.00
AquaBounty Technologies (AQB) United States $0.298B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.290B 0.00
Puma Biotechnology (PBYI) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.281B 0.00
XOMA (XOMA) United States $0.275B 115.81
Beyond Air (XAIR) United States $0.272B 0.00
Checkpoint Therapeutics (CKPT) United States $0.262B 0.00
Cardiff Oncology (CRDF) United States $0.259B 0.00
IBio (IBIO) United States $0.244B 0.00
Frequency Therapeutics (FREQ) United States $0.243B 0.00
Kamada (KMDA) Israel $0.239B 19.85
OVID THERAPEUTC (OVID) United States $0.235B 2.06
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
Kaleido Biosciences (KLDO) $0.229B 0.00
Adicet Bio (ACET) United States $0.225B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.224B 0.00
Adverum Biotechnologies (ADVM) United States $0.213B 0.00
Seelos Therapeutics (SEEL) United States $0.203B 0.00
NextCure (NXTC) United States $0.201B 0.00
Trevena (TRVN) United States $0.201B 0.00
Kala Pharmaceuticals (KALA) United States $0.200B 0.00
Talis Biomedical (TLIS) United States $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
SESEN BIO, INC (SESN) United States $0.183B 0.00
TELA Bio (TELA) United States $0.181B 0.00
ObsEva SA (OBSV) Switzerland $0.176B 0.00
CorMedix Inc (CRMD) United States $0.176B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
VolitionRX (VNRX) United States $0.170B 0.00
Synlogic (SYBX) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.165B 48.57
TScan Therapeutics (TCRX) United States $0.165B 0.00
HOOKIPA Pharma (HOOK) United States $0.164B 0.00
Aptinyx (APTX) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Galena Biopharma (SLS) United States $0.160B 0.00
ADMA Biologics Inc (ADMA) United States $0.159B 0.00
Catalyst Biosciences (CBIO) United States $0.159B 0.00
Erytech Pharma SA (ERYP) France $0.157B 0.00
LogicBio Therapeutics (LOGC) United States $0.146B 0.00
Dyadic (DYAI) United States $0.146B 0.00
Biofrontera AG (BFRA) Germany $0.145B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.145B 0.00
ATyr Pharma (LIFE) United States $0.144B 0.00
VTv Therapeutics (VTVT) United States $0.144B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 0.00
Nicox SA (NICXF) France $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
Novogen (KZIA) Australia $0.135B 0.00
Purple Biotech (PPBT) Israel $0.129B 0.00
Cyclerion Therapeutics (CYCN) United States $0.127B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Evofem Biosciences (EVFM) United States $0.123B 0.00
Eton Pharmaceuticals (ETON) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.122B 248.00
X4 Pharmaceuticals (XFOR) United States $0.119B 0.00
Exicure (XCUR) United States $0.119B 0.00
Yumanity Therapeutics (YMTX) United States $0.118B 0.00
Eyenovia (EYEN) United States $0.116B 0.00
Leap Therapeutics (LPTX) United States $0.115B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Voyager Therapeutics (VYGR) United States $0.114B 6.54
Viridian Therapeutics (VRDN) United States $0.114B 0.00
Entera Bio (ENTX) Israel $0.109B 0.00
Palatin Technologies (PTN) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Cocrystal Pharma (COCP) United States $0.103B 0.00
Armata Pharmaceuticals (ARMP) United States $0.097B 0.00
Pluristem Therapeutics (PSTI) Israel $0.095B 0.00
Aadi Bioscience (AADI) United States $0.090B 0.00
Celsion (CLSN) United States $0.089B 0.00
Lumos Pharma (LUMO) United States $0.088B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.080B 0.00
Advaxis (ADXS) United States $0.080B 0.00
Liminal BioSciences (LMNL) Canada $0.078B 0.00
Aytu BioPharma (AYTU) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.075B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
DiaMedica Therapeutics (DMAC) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Emmaus Life Sciences (EMMA) United States $0.071B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Longeveron (LGVN) United States $0.070B 0.00
Celyad SA (CYAD) Belgium $0.069B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
AIkido Pharma (AIKI) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Enveric Biosciences (ENVB) United States $0.057B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
AnPac Bio-Medical Science (ANPC) China $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.052B 1.08
Genetic Technologies (GENE) Australia $0.052B 0.00
Statera Biopharma (STAB) United States $0.050B 0.00
Vallon Pharmaceuticals (VLON) United States $0.049B 0.00
Forte Biosciences (FBRX) United States $0.049B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
ARIDIS PHARMACT (ARDS) United States $0.048B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Soligenix (SNGX) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Alimera Sciences (ALIM) United States $0.038B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.036B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Timber Pharmaceuticals (TMBR) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
ZIVO Bioscience (ZIVO) United States $0.031B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00